Gelsolin-related spinal and cerebral amyloid angiopathy

Annals of Neurology

Volumn 45, Issue 3, 1999, Pages 305-311

  Kiuru, Sari ^a,b   Salonen, Oili ^a   Haltia, Matti ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; CYSTATIN C; FIBRINOGEN; GELSOLIN;

AGED; AMYLOIDOSIS; ARTICLE; ATAXIA; CASE REPORT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CORNEA DYSTROPHY; DURA MATER; FACIAL NERVE PARALYSIS; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY GANGLION; SPINAL CORD; SPINAL ROOT; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AMYLOID; AMYLOID NEUROPATHIES; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; PEPTIDE FRAGMENTS;

EID: 0033028206     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199903)45:3<305::AID-ANA5>3.0.CO;2-E     Document Type: Article

References (46)

1. Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke 1987;18:311-324
2. Vinters HV, Wang ZZ, Secor DL. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996; 6:179-195
3. Glenner GG, Murphy MA. Amyloidosis of the nervous system. J Neurol Sci 1989;94:1-28
4. Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996;93:744-748
5. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci USA 1986;83:2974-2978
6. Vidal R, Garzuly F, Budka H, et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD18G). Am J Pathol 1996;148:361-366
7. Petersen RB, Goren H, Cohen M, et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 1997;41:307-313
8. Ishihara T, Nagasawa T, Yokota T, et al. Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis. Hum Pathol 1989;20:891-895
9. Sasaki A, Iijima M, Yokoo H, et al. Human choroid plexus is a uniquely involved area of the brain in amyloidosis. A histochemical, immunohistochemical and ultrastructural study. Brain Res 1997;755:193-201
10. Baumann MH, Wisniewski T, Levy E, et al. C-terminal fragments of α-and β-tubulin form amyloid fibrils in vitro and associate with amyloid deposits of familial cerebral amyloid angiopathy, British type. Biochem Biophys Res Commun 1996; 219:238-242
11. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969;1:314-324
12. Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. A review. Amyloid Int J Exp Clin Invest 1998;5:55-66
13. Ghiso J, Haltia M, Prelli F, et al. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 1990;272:827-830
14. Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990;136:1223-1228
15. Maury CPJ, Baumann M. Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1990;1096:84-86
16. de la Chapelle A, Tolvanen R, Boysen G, et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992;2:157-160
17. Levy E, Haltia M, Fernandez-Madrid I, et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990; 172:1865-1867
18. Paunio T, Kiuru S, Karonen SL, et al. Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid Int J Exp Clin Invest 1994;1:80-89
19. Kiuru S, Seppäläinen A-M, Salonen O, et al. CNS abnormalities in patients with familial amyloidosis of the Finnish type (FAF). Amyloid Int J Exp Clin Invest 1995;2:22-30
20. Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report of three cases. Acta Pathol Microbiol Scand [Sec A] 1971;79:432-440
21. Haltia M, Ghiso J, Wisniewski T, et al. Gelsolin variant and beta-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiol Aging 1991;12:313-316
22. Makishita H, Ikeda S, Yazaki M, et al. Postmortem pathological findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid Int J Exp Clin Invest 1996;3: 134-139
23. 654→A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992;13:237-239
24. Autti T, Raininko R, Santavuori P, et al. MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type. Neuroradiology 1997;39:371-377
25. Castaño EM, Ghiso J, Prelli F, et al. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease. Biochem Biophys Res Commun 1986;141:782-783
26. Pras M, Prelli F, Franklin EC, Frangione B. Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Nad Acad Sci USA 1983;80:539-542
27. Wang ZZ, Jensson O, Thorsteinsson L, Vinters HV. Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. APMIS 1997;105:41-47
28. Plant GT, Révész T, Barnard RO, et al. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain 1990;113:721-747
29. Adams RD, Victor M. Other somatic sensation. In: Adams RD, Victor M, eds. Principles of neurology. New York: McGraw-Hill, 1985:114-128
30. Dalakas MC, Quarles RH. Autoimmune ataxic neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens? Ann Neurol 1996;39:419-422
31. Kiuru S, Seppäläinen A-M. Neuropathy in familial amyloidosis, Finnish type (FAF). Electrophysiological studies. Muscle Nerve 1994;17:299-304
32. Sobue G, Nakao N, Murakami K, et al. Type 1 familial amyloid polyneuropathy. A pathological study of the peripheral nervous system. Brain 1990;113:903-919
33. Reilly MM, Staunton H. Peripheral nerve amyloidosis. Brain Pathol 1996;6:163-177
34. Klaus E, Freyberger E, Kavka G, Vodicka F. Familiäres Vorkommen von bulbärparalytischer Form der amyotrophischen Lateralsklerose mit gittriger Hornhautdystrophie und Cutis hyperelastica bei drei Schwestern. Psychiatr Neurol 1959; 138:79-97
35. Breteler MMB, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam study. Stroke 1994;25:1109-1115
36. Dupont RM, Jernigan TL, Heindel W, et al. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 1995;52:747-755
37. Haan J, Roos RAC, Algra PR, et al. Hereditary cerebral haemorrhage with amyloidosis-Dutch type. Brain 1990;113:1251-1267
38. Shimode K, Kobayashi S, Imaoka K, et al. Leukoencephalopathy-related cerebral amyloid angiopathy with cystatin C deposition. Stroke 1996;27:1417-1419
39. Van Nostrand WE, Wagner SL, Haan J, et al. Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid β-protein precursor. Ann Neurol 1992;32:215-218
40. Grubb A, Jensson O, Gudmundssson G, et al. Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med 1984;311:1547-1549
41. Yin H, Kwiatkowski DJ, Mole JE, Cole FS. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984;259:5271-5276
42. Kangas H, Paunio T, Kalkkinen N, et al. In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum Mol Genet 1996;5:1237-1243
43. Soto C, Castaño EM, Prelli F, et al. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett 1995;371: 110-114
44. Maeda A, Yamada M, Itoh Y, et al. Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy. Stroke 1993;24:1857-1864
45. Paunio T, Kangas H, Heinonen O, et al. Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis. J Biol Chem 1998; 273:16319-16324
46. Nodes BR, Shackelford JE, Lebherz HG. Synthesis and secretion of serum gelsolin by smooth muscle tissue. J Biol Chem 1987;262:5422-5427